Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention

被引：73
|
作者：
Stephenson, Kathryn E. [1 ,2 ]
Wagh, Kshitij [3 ,4 ]
Korber, Bette [3 ,4 ]
Barouch, Dan H. [1 ,2 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
[2] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Boston, MA 02114 USA
[3] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA
[4] New Mexico Consortium, Los Alamos, NM 87545 USA
来源：
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 | 2020年 / 38卷
基金：
美国国家卫生研究院;
关键词：
vaccine; broadly neutralizing antibody; HIV-1; viral diversity; prevention; bNAb; HUMAN-IMMUNODEFICIENCY-VIRUS; DEMAND PREEXPOSURE PROPHYLAXIS; CELLULAR IMMUNE-RESPONSES; MUCOSAL SHIV CHALLENGE; T-LYMPHOCYTE RESPONSES; HIGHLY PATHOGENIC SIV; ENVELOPE TRIMER; DOUBLE-BLIND; ANTIRETROVIRAL PROPHYLAXIS; ANTI-HIV-1; ANTIBODIES;
D O I：
10.1146/annurev-immunol-080219-023629
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Development of improved approaches for HIV-1 prevention will likely be required for a durable end to the global AIDS pandemic. Recent advances in preclinical studies and early phase clinical trials offer renewed promise for immunologic strategies for blocking acquisition of HIV-1 infection. Clinical trials are currently underway to evaluate the efficacy of two vaccine candidates and a broadly neutralizing antibody (bNAb) to prevent HIV-1 infection in humans. However, the vast diversity of HIV-1 is a major challenge for both active and passive immunization. Here we review current immunologic strategies forHIV-1 prevention, with a focus on current and next-generation vaccines and bNAbs.
引用
收藏
页码：673 / 703
页数：31
相关论文
共 50 条
  • [1] Broadly Neutralizing Antibodies for HIV-1 Prevention
    Walsh, Stephen R.
    Seaman, Michael S.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] Broadly Neutralizing Antibodies and their Significance for HIV-1 Vaccines
    Gonzalez, Nuria
    Alvarez, Amparo
    Alcami, Jose
    [J]. CURRENT HIV RESEARCH, 2010, 8 (08) : 602 - 612
  • [3] Broadly neutralizing antibodies for HIV-1 prevention and therapy
    Julg, Boris
    Barouch, Dan
    [J]. SEMINARS IN IMMUNOLOGY, 2021, 51
  • [4] Use of broadly neutralizing antibodies for HIV-1 prevention
    Pegu, Amarendra
    Hessell, Ann J.
    Mascola, John R.
    Haigwood, Nancy L.
    [J]. IMMUNOLOGICAL REVIEWS, 2017, 275 (01) : 296 - 312
  • [5] Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
    Haynes, Barton F.
    Wiehe, Kevin
    Borrrow, Persephone
    Saunders, Kevin O.
    Korber, Bette
    Wagh, Kshitij
    McMichael, Andrew J.
    Kelsoe, Garnett
    Hahn, Beatrice H.
    Alt, Frederick
    Shaw, George M.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2023, 23 (03) : 142 - 158
  • [6] Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
    Barton F. Haynes
    Kevin Wiehe
    Persephone Borrow
    Kevin O. Saunders
    Bette Korber
    Kshitij Wagh
    Andrew J. McMichael
    Garnett Kelsoe
    Beatrice H. Hahn
    Frederick Alt
    George M. Shaw
    [J]. Nature Reviews Immunology, 2023, 23 : 142 - 158
  • [7] Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
    Cohen, Yehuda Z.
    Caskey, Marina
    [J]. CURRENT OPINION IN HIV AND AIDS, 2018, 13 (04) : 366 - 373
  • [8] Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
    Awan, Seemal F.
    Happe, Myra
    Hofstetter, Amelia R.
    Gama, Lucio
    [J]. CURRENT OPINION IN HIV AND AIDS, 2022, 17 (04) : 247 - 257
  • [9] Rational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1
    Kwong, Peter D.
    Mascola, John R.
    Nabel, Gary J.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2011, 1 (01):
  • [10] FOCUS ON RESEARCH Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy
    Caskey, Marina
    Klein, Florian
    Nussenzweig, Michel C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2019 - 2021
12345